Advancing a Brain-Targeted AAV Gene Therapy for Alzheimer’s Disease
- Evaluating functional RNA silencing in the brain
- Advancing brain-targeted viral vector design
- Exploring the path from preclinical success to clinical impact
This event has run. Thank you to our speakers, sponsors, and delegates who joined us for the 2025 summit.
Returning 2026